Merial has announced the UK launch of updated ProteqFlu, the first and only EI vaccine in Europe to contain a clade 2 strain.
The company says the new vaccine is also the only one that is fully compliant with the latest 2014 OIE recommended EIV strains.
Louise Radford MRCVS from Merial said: "The launch marks the UK's first and only fully updated equine flu vaccine that contains both a Clade 1 and Clade 2 antigen which includes protection against the latest Florida Clade 2 strain, Richmond 07. This is a significant step for horse health, and the equine industry as a whole."
Hervé Poulet, Merial's head of BioDevelopment and BioResearch said: "Merial has developed strong and unique expertise in the development of non-replicative recombinant canarypox virus-vectored vaccines for various species and diseases.
"For the development of ProteqFlu, our non-replicative recombinant canarypox vector expressing the EI virus haemagglutinin (HA) is used because of its ability to induce a strong cellular immunity which is an essential component in protecting against this highly contagious disease."
Louise added: "ProteqFlu has also demonstrated its success and efficacy in real outbreaks, particularly during the last major outbreak, in Australia in 2007. ProteqFlu was the only vaccine chosen for the eradication programme."
Academics from the University of Bristol's School of Veterinary Sciences and the neurology team at Southmead Hospital Bristol have published the results of study examining the use of percutaneous electrical nerve stimulation (PENS) therapy as a treatment for headshaking syndrome in horses.
The authors say that the condition, a neuropathic facial pain syndrome, often leaves affected horses impossible to ride and dangerous to handle, and can result in euthanasia. At present there are no consistently safe and effective methods for the treatment of headshaking in horses, and the condition is estimated to affect between 10,000 and 20,000 horses in the UK.
The study, which is published in the Equine Veterinary Journal (EVJ), aimed to discover whether PENS therapy, developed by Algotec Research and Development Ltd, is safe, effective and sustainable for the management of trigeminal-mediated headshaking in horses.
Seven horses diagnosed with trigeminal-mediated headshaking were recruited to the trial. All procedures were carried out in sedated horses with a needle-prick sized area of skin desensitised with local anaesthetic to help probe insertion. A disposable PENS probe was placed just beneath the skin adjacent to the nerve under ultrasonographic guidance. The nerve was stimulated for 25 minutes following a protocol of alternating frequencies and a perception threshold based on human clinical data. The probe was removed and the procedure repeated on the other side. Three or four treatments were used during the protocol, with treatments being repeated when signs of headshaking recurred.
All horses tolerated the procedure well. Three horses developed a haematoma at the site on one occasion and two had increased clinical signs for up to three days following first treatment. Six horses responded well after the first treatment and returned to ridden work at the same level before headshaking began. Five horses continued to respond to further treatment.
Veronica Roberts, Senior Clinical Fellow in Equine Medicine in the University's School of Veterinary Sciences, who led the study, said: "Headshaking in horses is a major welfare issue and can be a significant cause of distress.
"Although it is clear that further work is required, including increasing the number of cases and refining the treatment procedures, the study shows that PENS therapy should be the first-line treatment for trigeminal-mediated headshakers, which have failed to respond to conservative treatment, such as nose-nets."
Reference
Elanco Animal Health has launched Vulketan, a POM-V sterile topical gel developed to encourage the healing of equine wounds.
Vulketan contains ketanserin - a serotonin-S2 antagonist.2 Elanco says that although serotonin is more widely known as a neurotransmitter in the brain, it is also found in platelets and released during platelet aggregation where it can have negative effects on wound healing.4, 7
Managing equine wounds is an everyday occurrence in equine practice1 and can be difficult and time-consuming, with many potential complications such as infection or the development of proud flesh which could delay healing or lead to reduced functionality. Repeated dressings can be a hassle for owners, and if used inappropriately can lead to their own complications.5
Elanco representative Kirsty Prudon said: "Vulketan gel is easy to use and is designed to be applied to undressed wounds, although it has been demonstrated that wounds may be dressed, if required, without affecting Vulketan's efficacy2,6.
Elanco also points to studies which it says demonstrate that Vulketan has been shown in client owned horses to be highly effective in preventing the formation of hypergranulation tissue and may facilitate the control of secondary infections.2,3,6. In addition, owners expressed satisfaction with Vulketan in over 90% of cases.6
Practising equine vet Linda Belton MRCVS said: "Vulketan is easy to use, well tolerated by horses and produces an excellent end cosmetic result and return to function. With the reduction in the need for dressings and proud flesh control Vulketan has proven to be an advantageous product which owners value."
Vulketan is suitable for use in all horses including pregnant and lactating mares. It is supplied in 75 gram tubes and should be applied twice daily.
For more information, contact your Elanco territory manager call Elanco on 01256 353131.
References
Boehringer Ingelheim Vetmedica has launched Equisolon 33 mg/g oral powder, the first licensed oral prednisolone for the alleviation of inflammation associated with recurrent airway obstruction (RAO), otherwise known as heaves, in horses.
Clare Turnbull, equine brand and technical manager at Boehringer Ingelheim Vetmedica said: "Oral glucocorticoids are sometimes necessary for treating the inflammation associated with RAO. We feel it is important that when our customers need to use prednisolone for their cases, there is an equine specific product available to them that is easy to dispense and administer."
The company says Equisolon should be used in combination with environmental measures to treat RAO.
For further information on Equisolon, contact your Boehringer Ingelheim Vetmedica equine representative or call +44 (0)1344 746959.
The British Equine Veterinary Association (BEVA) has clarified regulations on equine dental procedures following a survey which showed confusion, even amongst vets, over who is allowed to do what in a horse's mouth.
In the survey of BEVA members, more than half were unaware of the dentistry techniques that equine dental technicians (EDTs) are permitted to perform and the levels of veterinary supervision required.
In response, the association has put together a new information leaflet which explains the regulations surrounding equine dental care and describes where recommended practice differs from the letter of the law.
All diagnostic and treatment procedures in the horse's mouth are Acts of Veterinary Surgery under the Veterinary Surgeons Act 1966. The only exception is the manual removal of small dental overgrowths and sharp enamel points with hand instruments.
However it is acknowledged that there are a limited number of procedures that, despite being considered Acts of Veterinary Surgery, may be delegated safely to suitably qualified EDTs without compromising the horse's welfare and safety. In 2009 the RCVS, with assistance from BEVA, BVDA and BAEDT, listed these processes and categorised all dental procedures into three groups:
Despite there being no legal basis supporting non-vets performing Category 2 procedures, the RCVS has stated that there would be no public interest in prosecuting vets who collaborate with suitably qualified EDTs to perform non-invasive (Categories 1 and 2) procedures.
BEVA recommends that, for their own protection, all vets who deal with horses:
Vicki Nicholls, equine vet at Wright and Morten in Cheshire, chair of BEVA council's Paraprofessional Committee and member of the British Association of Equine Dental Technicians (BAEDT) said: "The lack of awareness is alarming and clearly emphasises the need to make vets and equine dental technicians fully conscious of current regulations regarding equine dentistry. Non-adherence to the regulations is a serious matter and could lead to prosecution of the veterinary surgeon, EDT and/or owner."
The number of vets taking the BEVA/BVDA exam in equine dentistry has increased in recent years with about 15% of those who have passed the exam being vets. BEVA says this is indicative of the growing awareness, amongst owners and vets, of the importance of dental health. It also reflects a desire to develop and demonstrate both practical skills and a theoretical understanding of equine dental care to augment the vet's broader medical knowledge. Expertise in equine dental care has, for many veterinary practices, become a valuable asset.
Copies of the dental regulations information leaflet can be downloaded from the BEVA website at www.beva.org.uk. BEVA also runs regular dentistry CPD courses, details of which can be found on the website.
Image source: Rachel C from Scotland
This year's National Equine Health Survey, conducted by the Blue Cross and supported by Zoetis, has revealed that 20% of owners who claimed to have treated for encysted small redworm (ESRW) used a wormer that was not indicated to treat the parasite.
3,669 horse owners took part in the survey, which was conducted in May 2014. It contained 25 questions on general horse health, care and management and was validated by Professor Josh Slater at the Royal Veterinary College.
Zoetis says the findings suggest that horses are being left at serious risk (untreated, encysted small redworm may develop and emerge en masse from the gut wall, causing diarrhoea and colic with a mortality rate of up to 50%1).
The company is now running an encysted small redworm awareness campaign at www.esrw.co.uk, where owners can test their knowledge before discussing the best treatment options with their vet.
1. Dowdall S.M.J. et al (2002) Veterinary Parasitology 106, 225‑242
BCF has announced the launch of the wireless Cuattro Slate 4 equine DR system.
BCF says the new system is available with an Automatic Exposure Detection (AED) panel, which means the plate automatically recognises the radiation from the generator, with no need for a sync cable.
Gavin Mitchell from BCF said: "This system now makes the connection from any generator to the plate and from plate to tablet now wireless. This is the new revolution for equine DR. Our rugged tablet design makes it easy to show your client your images. All you need to carry with you is the plate, tablet and generator. So much lighter to transport than previous DR systems and now also easier to move around the horse."
Sarah O'Grady from BCF added: "The powerful Cuattro software is so intuitive to use, allowing you to easily customise how your image looks. A simple three step process to take an image and just one button press to back-up images to PACS or the Cloud, makes the Slate so easy to use. If you are considering upgrading to DR or replacing your old DR system, then make sure you try out the new Slate 4."
For more information, visit www.bcftechnology.com or ask your local Account Manager for a free trial.
Zoetis has launched UlcerGold (omeprazole) for the treatment - and prevention of recurrence - of gastric ulcers in horses and foals, presented in a syringe suitable for foals from four weeks of age and horses from 70 to 700kg.
Equine Gastric Ulceration Syndrome (EGUS) is a serious and common condition affecting horses and foals.2,3 Approximately 90% of racehorses, 60% of performance horses, 37% of leisure horses and 50% of foals have been shown to be affected.2,4,5 The condition is associated with injury to the mucosa of the oesophagus, stomach and duodenum, with prolonged exposure to gastric acid thought to be the primary cause.2,3 Risk factors include stress, intense exercise, a high-grain diet, intermittent feeding and illness.2,3 EGUS can have a profound impact on a horse's condition and performance and can ultimately be life threatening, especially in foals.3,5 It is a challenging condition to diagnose as the clinical signs are often vague and not always present.3 Gastroscopy is the only method currently available for a definitive diagnosis and treatment is usually based on acid suppressive therapy to allow ulcer healing.2
UlcerGold is indicated to treat and prevent the recurrence of gastric ulcers in horses, administered once-daily for 28 consecutive days at the full dose of 4mg/kg bodyweight followed by the reduced dose of 1mg/kg bodyweight for a further 28 days.1 It contains omeprazole, a proton pump inhibitor that suppresses gastric acid secretion.1,2 One syringe contains enough UlcerGold for a horse weighing up to 700kg. It can be used for foals as young as four weeks of age that weigh over 70kg and for breeding stallions.
Zoetis says UlcerGold is supported by a comprehensive gastroscope training programme, pricing model, client support and communications plan to ensure that it is a strong asset to veterinary businesses.
Penny McCann, Equine Product Manager, Zoetis UK Ltd, said: "UlcerGold is an exciting addition to our equine POM-V portfolio. We have designed a training, education and business programme to help practices make sure they get the best from our new product, not only in terms of gastric ulceration treatment but also practice health."
Andrew Harrison, a partner at Three Counties Equine Hospital in Gloucestershire, has been appointed as the new President of the British Equine Veterinary Association (BEVA) for 2014/15.
Andrew took over the role from Paul Jepson at the end of BEVA Congress last week. Mark Bowen, Associate Professor of Veterinary Internal Medicine at The University of Nottingham School of Veterinary Medicine and Science, becomes President Elect.Andrew said: "It is a privilege and an honour to take up the presidential reins for the next 12 months. It is unrealistic to expect to "change the world" in such a short time frame so the plan is to target certain areas, such as progressing New Safer Horse Rescue courses, strengthening BEVA's relationship with the BHA and moving forward with the regulation of Musculoskeletal Paraprofessionals. Not least it is a priority this year to make sure we keep aspiring vets realistically informed about future employment in our profession given the proliferation of undergraduate places available at UK and English speaking mainland European vet schools."
For further information visit www.beva.org.uk.
The British Equine Veterinary Association has published the results of a survey it commissioned which found that horse vets in the UK are probably at greater risk of injury than any other civilian profession, including the prison service.
For the study, which was conducted by the Institute of Health and Wellbeing and the School of Veterinary Medicine at the University of Glasgow, 620 equine vets completed a work-related injuries questionnaire. The results of the study indicated that an equine vet could expect to sustain between seven and eight work-related injuries that impeded them from practicing, during a 30-year working life.
If the 620 respondents were representative of the rest of the profession, the injuries they reported would equate to 26,452 per 100,000 equine vets in employment per year. That compares with 10,760 for people working in the prison service, 8,700 for policemen below the rank of sergeant, 6,980 for welders, metal formers and related trades, and 4,760 for construction workers.
Participants were asked to describe their worst-ever injury. Most were described as bruising, fracture and laceration, with the most common site of injury being the leg (29%), followed by the head (23%). The main cause of injury was a kick with a hind limb (49%), followed by strike with a fore limb (11%), followed by crush injury (5%). Nearly a quarter of these reported injuries required hospital admission and notably, 7% resulted in loss of consciousness. The most common reason for the examination during which the injury occurred was foot lameness, followed by dental and female reproductive.
BEVA Past-President Keith Chandler said: “We were shocked to discover the extent of the injuries sustained. Of greatest concern is the number of vets who suffered head injuries and unconsciousness. These injuries appeared to be more common when certain procedures were being performed, such as endoscopy of the upper respiratory tract, when vets are often only partly sighted while using examination equipment, or during wound management and bandage-changes, where vets are often crouched-down for long periods, next to the patient.”
38% of the ‘worst’ injuries occurred when the vet was working with a ‘pleasure’ horse and most frequently (48% of all responses) the horse handler was the owner or the client at the time of the injury. Whilst the number of laypersons or handlers injured at the same time was low, Tim Parkin, vet and lead researcher, pointed out: “This work should act as a wake up call to all involved in the training, employment and engagement of equine vets. The risks associated with handling and working with horses should be the primary consideration for equine vets and horses owners alike, every time a horse is examined or treated. In addition, the experience of the horse handler should be considered when undertaking riskier procedures.”
David Mountford, Chief Executive of BEVA said: “The results are very concerning and justify a careful prospective scientific quantification of the risks. In the short term, knowledge of these risks allows us to better inform all vets who work with horses. In turn vets will be able to inform horse owners, horse-keepers and trainers of the risks, and this may provide justification for having trained assistance on-hand or the more extensive use of sedative drugs in practice, potentially reducing the risk of injury.
"The British Equine Veterinary Association will now look to work with the Health and Safety Executive, Veterinary Schools, large employers of vets in the UK and our members to help develop policies to mitigate the risk of serious injury for vets working with horses.”
Photograph courtesy Towcester Veterinary Centre
Dechra Veterinary Products has launched Osphos, an intramuscular clodronic acid injection for the control of clinical signs associated with the bone resorptive processes of navicular syndrome in horses, the only such licensed product in the UK.
Dechra says it expects Osphos to change the way chronic lameness caused by navicular syndrome is tackled by equine vets.
According to the company, clinical trials of Osphos showed 74.7% of horses experienced improvement by at least one lameness grade at 56 days post treatment.
Dechra brand manager Emma Jennings said: "Osphos intramuscular injection contains the bisphosphonate clodronic acid which inhibits resorption in the navicular bone by binding to hydroxyapatite crystals and by direct cellular effects on osteoclasts.
"We are delighted with the results of the trials, which proved that Osphos is effective at 6 months post-treatment. We're looking forward to being able to support equine vets, vet nurses and practices by providing an intramuscular Clodronic acid injection for horses."
Dechra also says studies showed that mild transient colic was seen following just 1.6 per cent of treatments.
Osphos 60 mg/ml solution for injection for horses is available from September 2014.
The Royal Veterinary College and the Animal Health Trust are trying to recruit 3000 horse and pony owners to take part in 'CARE about laminitis', a web-based research project that aims to reduce the threat caused by laminitis.
The four-year study, which is being funded by World Horse Welfare, is being conducted by PhD student, Danica (Dee) Pollard, based at the AHT. The main aims of the study are to:
Currently the veterinary-reported frequency of laminitis in Britain, estimated between 2009 and 2011, shows that active episodes of veterinary-diagnosed laminitis occurred in nearly 1 in 200 horses/ponies registered with veterinary practices, and accounted for nearly 1 in 200 equine visits. Dee said: "However an overall lack of studies into the frequency of laminitis leaves little to compare these estimates with."
If you'd like to take part in the study, or invite clients to do so, visit: www.careaboutlaminitis.org.uk or email danica.pollard@aht.org.uk.
Merial is inviting all equine veterinary surgeons that are going to BEVA Congress this year to the launch of updated ProteqFlu, its equine flu vaccine which now includes protection against the latest Clade 2 strains, including Richmond 07.
Speakers at the event include specialist Dr Richard Newton (pictured right), Head of Epidemiology and Disease Surveillance at the Animal Health Trust (AHT), and Dr Romain Paillot Head of Immunology at the AHT. Dr Newton will explain why the inclusion of the Clade 2 strain is so important for horse health, and the equine industry as a whole.
Louise Radford MRCVS from Merial said: "We're all incredibly excited as the event will mark the launch of the UKs first and only fully updated equine flu vaccine that contains both a Clade 1 and Clade 2 antigen. The new ProteqFlu® vaccine fully represents the latest 2014 OIE recommended EIV strains."
The launch is being held at the Hotel Du Vin, Birmingham on Thursday 11 September 2014. Presentations will cover 'A virological and immunological perspective on Clade 2 & EIV', 'How technology makes the difference' and independent vaccine trial results.
The evening starts at 6.30pm and includes dinner and evening entertainment.
To book, contact, Jo Gater-Willats, or Merial Customer Support on 0800 6000123.
New research from the Animal Health Trust (AHT), published in the Equine Veterinary Journal, shows that equine obesity is an increasing but under-recognised welfare issue in the UK.
Data collected from 785 horses and ponies (31% of which were classified as obese), over a two-year period between 2009 and 2011, has been used to explore various elements that contribute to the risk of obesity in British horses and ponies.
The research, funded by World Horse Welfare, identified several factors which may increase the risk of being obese. Pony breeds, particularly UK native breeds and heavier horses such as draught and cobs types were all significantly more likely to be obese compared to Thoroughbred horses. Charlotte Robin, Research Assistant at the AHT and lead author of the paper, said: "Native breeds may be genetically better adapted to survive in harsh conditions, having a so-called thrifty genotype, increasing their risk of obesity when maintained in an environment where food is of better quality and more readily available."
Horses that were described by their owners as readily being able to gain weight or being "good doers" were more than three times more likely to be obese, compared to those that normally maintained weight.
The research also highlighted various links to human obesity. Charlotte said: "In humans, obesity is associated with poor health status and chronic health conditions including diabetes, hypertension, respiratory disease and arthritis. Similar associations between obesity and adverse health events have been described in equines."
Similarly in humans, exercise significantly improves insulin sensitivity, and it is thought the same "dose-response" effect is mirrored in horses. For example, the AHT's research highlighted that the risk of obesity is greater in pleasure or non-ridden horses, with pleasure horses being more than twice as likely to be obese and non-ridden horses being nearly three times more likely to be obese. Competition animals will receive increased exercise at a higher intensity and be fitter than non-competition animals, further reducing the risk of obesity. Charlotte added: "Competition horses are likely to be managed in different ways compared to non-competition or non-ridden animals and this may also contribute to the reduced risk of obesity within this sub-population."
World Horse Welfare's Deputy Head of UK Support, Sam Chubbock said: "Excess weight is one of the greatest challenges facing horse owners in the UK today, which is why we supported this vital research. Being overweight can be just as much, if not more, of a health concern as being underweight. In our experience it can take three times longer to get an overweight horse back to optimum condition than it can a thin horse. Moreover, a previously obese horse's weight will need to be managed for the rest of its life, even after the weight has come off, and they are likely to suffer long-term effects. Managing a horse prone to weight gain can be incredibly difficult and this is why our Right Weight project provides practical guidance for owners on how to assess and manage their own horse's weight."
The AHT says its obesity research has helped to highlight obesity as a significant equine welfare issue and provided valuable information for owners. People frequently misclassify their own weight or body shape, and this phenomenon also applies to perceptions about our pets' weight. Dog and horse owners have been demonstrated to underestimate their animals' weight, suggesting the prevalence of obesity in this study is likely to be an underestimation.
Charlotte said: "It is possible that in certain breeds, being overweight or obese has been normalised to a certain extent. Owners may find it easier to identify an overweight Thoroughbred, compared to an overweight cob or native pony.
"Helping owners identify when their horse is overweight or obese is an essential aspect of reducing the welfare impact of equine obesity."
XLEquine and the Animal Health Trust (AHT) have launched Plan, Prevent, Protect, billed as the UK's first equine biosecurity booklet for horse owners and yard managers to work through with their veterinary surgeon, to minimise disease risk on yards and maintain the health and welfare of the horses in their care.
Mark Tabachnik MRCVS, of XLEquine member practice Wright & Morten Veterinary Surgeons said: "For many yard and horse owners, biosecurity is just not on their radar. It only becomes important after they have had an outbreak! Strangles in particular can have devastating effects which impact not only on horse welfare, but the disruption and paralysis of animal movement has significant consequences with relationships on the yard, not to mention the financial costs in some cases.
"We wanted to develop a practical guide that pre-empts these issues by helping owners to set in place simple and in many cases common sense, plans and procedures to prevent a disease outbreak, along with practical steps should the worst happen, and an outbreak occurs.
"Our veterinary farm colleagues and the medical profession are well ahead in terms of biosecurity measures. It's about changing people's mind-sets. For example the NHS "Catch it Bin it Kill it" campaign has been highly successful in adapting our thoughts and actions towards disease spread, and consequently many of us are more aware of the importance of good biosecurity in one way or another."
Dr Richard Newton, Head of Epidemiology and Disease Surveillance at the AHT was also involved in the development of the booklet. He said: "I hope that this will encourage all equine practices to raise their game, it is so important for the whole equine community."
The booklet is available to all equine clients of XLEquine member practices, or it is available to view at http://www.xlequine.co.uk/content/plan-prevent-protect
Merial has announced the launch of a new Blippar app designed to educate horse owners about gastric ulcers.
By using the app - which is available free from the App Store for iPhone or Google Play for Android phones - to scan the company's Gastrogard (omeprazole) adverts, posters or website, clients can watch an educational film with one of the UK's leading specialists in equine ulcers, Richard Hepburn BVSc MS(Hons) CertEM(IntMed) DipACVIM(LA) MRCVS, American and RCVS Specialist in Equine Internal Medicine, demonstrating the signs of ulcers and diagnosis via gastroscopy.
Merial's Equine Marketing and Technical Manager Louise Radford MRCVS said: "With 60% of competition horse and 38% of leisure horses & ponies estimated to have gastric ulcers¹,²,³, it's important that horse owners are aware of the signs of this under-diagnosed condition.
"We know that the number of horses diagnosed and treated for ulcers falls significantly short of incidence levels. We hope that this app will help to raise awareness and prompt more horse owners to consult their vet about gastric ulceration."
A separate Blippar app is also available for horse owners that have been prescribed GastroGard. By scanning the pack, clients can view educational video footage on gastric ulcers, find management tips on treatment and prevention, and set a reminder for future risk periods.
For more information, visit: http://www.equinegastriculcers.co.uk, contact your local Merial equine territory specialist or call Merial Customer Support on 0870 6000123.
Horiba UK is to launch Gluco Calea, a new handheld blood glucose meter developed and calibrated for monitoring sugar levels in the whole blood of cats, dogs and horses, at BSAVA Congress this year.
Horiba says the new product is highly accurate and easy-to-use for the assessment of Type 1 and Type 2 Diabetes Mellitus in animals. It is also designed to be used both in veterinary practice and at home for regular monitoring and subsequent treatment optimisation.
The Gluco Calea uses disposable test strips that can measure glucose from 0.5 µL of capillary whole blood. In addition, its memory will store 300 test results and display blood glucose averages for 7, 14 and 30 days.
Paul Lymer, Veterinary Market Specialist at Horiba said: "Using a meter calibrated for humans when measuring animal blood glucose may result in inaccurate readings and an underestimation of blood glucose. This is because animals and humans have very different blood compositions, notably the concentration of glucose in blood plasma is significantly higher in animals. Therefore, it is essential to use a blood glucose meter specifically developed for animals such as the Gluco Calea."
Horiba is also highlighting 'Gold energy plus liquid sugar', its new vanilla-flavoured gel for hypoglycemia in small animals. The company says it is easy to give, rapid acting and highly effective over a long period.
For more information and a special offer whereby you can claim a free Gluco Calea meter with every purchase of 50 test strips, visit stand 505 at the BSAVA Congress, or www.horiba.com/uk/medical/products/animal-healthcare.
Vétoquinol has announced the return of Navilox powder (isoxsuprine hydrochloride), the only medication specifically licensed in the UK for use in cases of navicular disease in horses.
Navicular disease is a chronic degenerative condition of the navicular bone and associated structures. It is a syndrome with a complex pathogenesis which combines various underlying causes. Vétoquinol says it is a common cause of lameness in the middle aged riding horse.
Robert Simpson, Navilox Product Manager said: "Navilox has been sorely missed by equine vets in the UK which is why I am thrilled to be able to announce that it is available again."
To order Navilox powder, call Vétoquinol on 01280 825424 or contact your wholesaler directly.
Kruuse UK has announced the launch of its new Mud Fever Kits for horses.
Kruuse says the launch follows independent studies last year by Aimi Duff BVM&S, MRCVS (Scott, Mitchell & Associates, Hexham) on the use of Manuka ND dressings for the treatment of Mud Fever.
The kit contains one complete treatment for two legs (or two complete treatments for one leg) including all dressings. There is also a step-by-step guide from the "Ask the Vet" series which explains best treatment protocol, designed to help veterinary surgeons dispense the kit directly to clients with confidence.
According to the company, the benefits of using medical grade Manuka Honey in the treatment of Mud Fever include:
Andrew Groom, Managing Director of Kruuse UK Ltd said: "We are delighted with the initial response to our unique Mud Fever Kits; such additions to our range continue to enhance the Kruuse commitment to equine wound care."
Dechra Veterinary Products has launched Buprenodale, an opioid analgesic for cats, dogs and horses presented in a 10ml multi-dose vial.
Carol Morgan, Brand Manager said: "Following on from the introduction of Comfortan and Anesketin, our Buprenodale Multidose, 0.3 mg/ml solution for injection for dogs, cats and horses, is the latest addition to the portfolio.
"The active substance in Buprenodale is buprenorphine, the most commonly used opioid analgesic in small animal practice in the UK.
"Buprenodale Multidose joins a portfolio of Dechra products covering a wide range of species, different levels of analgesic efficacy and duration of action.
"The product is now available in a 10 ml multidose vial. It is suitable for post-operative analgesia in dogs and cats; post operative analgesia, in combination with sedation, in horses and potentiation of the sedative effects of centrally acting agents in the dog and horse."
For more information www.dechra.co.uk .
Horses suffering from neurological conditions similar to those that affect humans could be helped by a breakthrough from stem cell scientists, according to a study published in the journal Stem Cells and Development.
Researchers at the University of Edinburgh's Roslin Institute took skin cells from a young horse and turned them into stem cells using a technique that was originally developed for human cells. The reprogrammed cells are pluripotent, which means they can be induced to become any type of cell in the body. The team used them to create nerve cells in the laboratory and tested whether they were functional by showing that they could transmit nerve signals in a test tube.
The university says horse stem cells have been produced in the laboratory before but this is the first time that scientists have created working cells of a specific type from them. The advance may pave the way for cell therapies that target conditions similar to motor neurone disease.
In addition, the research could also benefit horses affected by grass sickness, a neurological condition that affects around 600 horses a year in the UK. Little is known about the disease, which causes nerve damage throughout the body. It is untreatable and animals with the most severe form usually die or have to be put down.
Dr Xavier Donadeu from the Roslin Institute, an author of the study, said: "Stem cells hold huge therapeutic potential both for people and animals. Our research is an important step towards realising that potential for horses and provides an opportunity to validate stem-cell based therapies before clinical studies in humans."
A new US colic study, published in Equine Veterinary Journal (EVJ), in partnership with the American Association of Equine Practitioners, has identified various risk factors, including delayed faecal output and increasing blood lactate, associated with post-anaesthetic colic.
The study Risk factors associated with gastrointestinal dysfunction in horses undergoing elective procedures under general anaesthesia was conducted by surgeons based at the College of Veterinary Medicine and Biomedical Sciences at Colorado State University, USA.
The authors say that the research should enable vets to implement preventative measures to help reduce incidences of colic in the future.
Gastrointestinal pain has been estimated to occur in 2.8-6% of horses following general anaesthesia for elective procedures, the most common cause being impaction of the large intestine or caecum.
The medical records of 416 horses undergoing general anaesthesia were collected over a two-year period and the potential risk factors were examined. 8.7% of horses were diagnosed with gastrointestinal dysfunction - higher than previous estimates probably because the study included horses requiring treatment for decreased faecal output whereas previous studies did not. Potential risk factors were assessed, including faecal output, which was decreased in 38.9% of cases, blood lactate, position during surgery, rectal temperature and breed of horse.
The results showed that Arabian horses, increasing blood lactate, right lateral recumbency, decreased rectal temperature post-procedure and delayed passage of faeces were significantly associated with an increased risk of gastrointestinal dysfunction.
Diana Hassel, who instigated the study, said: "These findings should help the clinician identify higher risk horses and be proactive about their management in the post-anaesthetic period.
"This may include pre-emptive nasogastric intubation and administration of mineral oil and/or water and electrolytes. Although core temperature control in horses is difficult to achieve in adult horses during surgery, further research into this field may prove beneficial."
Professor Celia Marr, Editor of the Equine Veterinary Journal said: "This study brings obvious and immediate practical benefits for clinicians and the horses under their care. Rigorous monitoring of higher risk surgical cases should lead to a reduction in incidences of post-operative colic, making recovery procedures less difficult and outcomes more favourable."
Dechra Veterinary Products has launched Anesketin, an anaesthetic licensed for cats, dogs and horses.
Anesketin contains ketamine 100mg/ml solution for injection and is indicated for induction of anaesthesia. In cats, it can also be used as a sole agent for restraint and minor surgical procedures where muscle relaxation is not required.
Dechra Brand Manager Carol Morgan said: "Anesketin is a versatile product which can be used as a sole agent in cats or in combination with appropriate sedatives and analgesics in cats, dogs and horses for induction and maintenance of anaesthesia.
Anesketin is available in 10 ml vials. The withdrawal period for meat, offal and milk is one day and the product does not require any special storage conditions.
For further information, visit www.dechra.co.uk
Vetsonic has taken over the marketing of Cavalesse, the oral nutritional supplement for horses that are prone to skin allergies, such as sweet itch.
Cavalesse contains a formulation of water-soluble vitamins and minerals, administered daily via a special pipette, either by sprinkling over a small handful of feed or adding to a treat. Vetsonic claims the supplement helps horses maintain a healthy skin and promotes normal immune function.
Ray Rochester, Managing Director of Vetsonic said: "It's an exciting phase in the development of Vetsonic which will see us rapidly expanding in the increasingly competitive small animal and equine market. Cavalesse is a welcome addition to our portfolio."
For further information, contact Vetsonic customer services on 01653 695333.
Merial has announced the results of a survey which suggests that whilst diagnosis of gastric ulcers in horses is improving, there is still room for improvement.
The survey of 50 equine vets, which was conducted in May this year, showed that the number of practices owning a scope has more than doubled over the past six years. Half of equine practices now own a scope. Over the same period the average number of monthly scopes has risen from 1.5 to 9.25 and referrals from practices without a scope has risen by 65%.
Merial's Louise Radford MRCVS said: "The survey also showed that symptom recognition among vets prompting the need for an endoscopy has also risen. The vast majority of vets now consider changes in behaviour, loss of appetite and poor performance as potential signs. In addition, 100% of those surveyed would consider an endoscopy when presented with the signs of recurring colic.
"However whilst this is great progress, when diagnosis is compared to the incidence of ulcer, we know that more needs to be done. It is believed that up to 30% of leisure horses have some degree of gastric ulceration, and this increases in sports horses, yet just a fraction of this figure represents those scoped."
Richard Hepburn BVSc MS(Hons) CertEM(IntMed) DipACVIM(LA) MRCVS, American and RCVS Specialist in Equine Internal Medicine at B&W Equine Hospital says he is pleased that more horses are being scoped for gastric ulcers but says that further education is needed: "We've seen a huge leap in the appreciation of the incidence of gastric ulceration in non-racing animals, which long term will better our understanding of the individual clinical relevance of particular lesions, and the benefits of treatment and management change.
"This should improve both performance and horse welfare, as well as increasing client satisfaction. Despite the huge increase in the diagnosis and treatment of equine gastric ulcers it is still believed that many horses go undiagnosed."